{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:22:53Z","timestamp":1787239373547,"version":"build-2736575974"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    One hundred forty serogroup Y\n                    <jats:italic>Neisseria meningitidis<\/jats:italic>\n                    isolates recovered from patients with invasive meningococcal disease (IMD) in Canada from 1999 to 2003 were analyzed by genetic and serological methods. Seventy-four isolates (52.9%) belonged to serotype 2c, and most have serosubtype antigen P1.5,2 (37 isolates, 26%) or P1.5 (31 isolates, 22%). Forty-eight isolates (34.3%) belonged to serotype 14 and have serosubtype antigen P1.5,2 (13 isolates, 9%) or P1.5 (7 isolates, 5%) or were nonserosubtypeable (27 isolates, 19%). Thirteen isolates (9.3%) were nonserotypeable. Multilocus sequence typing identified two unrelated clonal populations of serogroup Y meningococci causing invasive disease in Canada: ST-23 and ST-167 clonal complexes. Almost all ST-167-related isolates were typed as 2c:P1.5, while strains of the ST-23 clonal complex were either serotype 14 or 2c but with the serosubtype antigen P1.5,2. In contrast to previous reports that patients with serogroup Y disease are usually older, 26% of the Canadian serogroup Y cases were found in the 10-to-19-year-old age group and another 11% were in the 20-to-39-year-old age group.\n                  <\/jats:p>","DOI":"10.1128\/jcm.02134-06","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T20:53:59Z","timestamp":1176929639000},"page":"1753-1758","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":23,"title":["Genetic and Antigenic Analysis of Invasive Serogroup Y\n                    <i>Neisseria meningitidis<\/i>\n                    Isolates Collected from 1999 to 2003 in Canada"],"prefix":"10.1128","volume":"45","author":[{"given":"Raymond S. W.","family":"Tsang","sequence":"first","affiliation":[{"name":"Laboratory for Vaccine Preventable Bacterial Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averil M.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Laboratory for Vaccine Preventable Bacterial Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa L.","family":"Cameron","sequence":"additional","affiliation":[{"name":"Laboratory for Vaccine Preventable Bacterial Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun D.","family":"Tyler","sequence":"additional","affiliation":[{"name":"DNA Core Facility, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Tyson","sequence":"additional","affiliation":[{"name":"DNA Core Facility, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K. S.","family":"Law","sequence":"additional","affiliation":[{"name":"Laboratory for Vaccine Preventable Bacterial Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stoltz","sequence":"additional","affiliation":[{"name":"Laboratory for Vaccine Preventable Bacterial Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell D.","family":"Zollinger","sequence":"additional","affiliation":[{"name":"Department of Bacterial Diseases, Walter Reed Army Institute of Research, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1987.tb02626.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(82)80010-3"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268896007261"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1998.tb12862.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1998.tb01379.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-25"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/428590"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268898001848"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90091-W"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.186.5.1518-1530.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90340-9"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.Supplement_1.S177"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(91)90338-Y"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/501371"},{"key":"e_1_3_2_16_2","first-page":"131","year":"2001","unstructured":"Kuipers, B., G. van den Dobbelsteen, E. Wedge, and L. van Alphen. 2001. Serological characterization, p. 131-145. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease: methods and protocols. Humana Press, Totowa, NJ.","journal-title":"Meningococcal disease: methods and protocols."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268804003413"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.6.3140"},{"key":"e_1_3_2_19_2","first-page":"927","year":"2001","unstructured":"Munford, R. S. 2001. Meningococcal infections, p. 927-930. In E. Braunwald, S. L. Hauser, A. S. Faucim, D. L. Longo, D. L. Kasper, and J. L. Jameson (ed.), Harrrison's principles of internal medicine, 15th ed., volume 1. McGraw-Hill, Washington, DC.","journal-title":"Harrrison's principles of internal medicine"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/09674845.2003.11783700"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.1.71"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000148928.10057.86"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2094"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000126297.28952.f8"},{"key":"e_1_3_2_25_2","unstructured":"Laboratory methods Neisseria and Branhamella. 1992"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/315158"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.3.348-354.1998"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.6.845-855.1998"},{"key":"e_1_3_2_30_2","first-page":"17","volume":"30","year":"2004","unstructured":"Squires, S. G., S. L. Deeks, and R. S. W. Tsang. 2004. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001. Can. Commun. Dis. Rep.30:17-28.","journal-title":"Can. Commun. Dis. Rep."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.9.2506-2508.1993"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45541-0"},{"key":"e_1_3_2_33_2","first-page":"391","volume":"13","year":"2002","unstructured":"Tsang, R. S. W., S. G. Squires, W. D. Zollinger, and F. E. Ashton. 2002. Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001. Can. J. Infect. Dis.13:391-396.","journal-title":"Can. J. Infect. Dis."},{"key":"e_1_3_2_34_2","first-page":"152","volume":"12","year":"2005","unstructured":"Tsang, R. S. W., and W. D. Zollinger. 2005. Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole cell enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol.12:152-156.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_35_2","first-page":"157","year":"2001","unstructured":"Urwin, R. 2001. Nucleotide sequencing of antigen genes of Neisseria meningitidis, p. 157-172. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease: methods and protocols. Humana Press, Totowa, NJ.","journal-title":"Meningococcal disease: methods and protocols."},{"key":"e_1_3_2_36_2","first-page":"47","year":"1978","unstructured":"Varughese, P. V., S. E. Acres, F. E. Ashton, J. A. Ryan, and B. B. Diane. 1978. Meningococcal disease in Canada, p. 47-63. In N. A. Vedros (ed.), Evolution of meningococcal disease, vol. II. CRC Press, Boca Raton, FL.","journal-title":"Evolution of meningococcal disease"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.6.1320"},{"key":"e_1_3_2_38_2","first-page":"97","volume":"32","year":"2006","unstructured":"Watkins, K. M., S. L. Deeks, A. Medaglia, and R. S. W. Tsang. 2006. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003. Can. Commun. Dis. Rep.32:97-107.","journal-title":"Can. Commun. Dis. Rep."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520290042027"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/313617"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.11.5146-5153.2004"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02134-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02134-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:57:55Z","timestamp":1646441875000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.02134-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1128\/JCM.02134-06"],"URL":"https:\/\/doi.org\/10.1128\/jcm.02134-06","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"2006-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-04-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}